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Introduction 
Dermatologic diseases, including acne, eczema, and 
psoriasis, have a strong emotional and social impact 
on patients and have a similar influence on quality of 
life (QoL) and disability as other chronic medical 
conditions such as heart disease, arthritis, and 
depression [1]. Illness perception (IP), defined as the 
cognitive and emotional representation of an illness 
or health threat held by an individual, is intricately 
linked with health-related behaviors, such as help-
seeking and treatment adherence [2]. IP has been 
extensively studied in a variety of chronic medical 
conditions and has been shown to affect objective 
outcomes, with a more positive IP being associated 
with higher engagement in rehabilitation efforts 
following myocardial infarction, greater self-
management of diabetes, and fewer physical 
symptoms in rheumatoid arthritis [3]. According to 
the self-regulatory theory by Leventhal, individuals 
develop cognitive and emotional representations 
about their health, which in turn influence the way 
they regulate their healthcare-related behaviors [4]. 
An illness is the subjective experience of living with a 
disease and will be different for each individual — 
both influencing, and being influenced by, the 
course of the disease, as well as other social, 
psychological, and environmental factors [5, 6]. 
Although QoL has been studied in relation to acne 
[7-11], eczema [12, 13], and psoriasis [14-17] there is 
little information on how patients conceptualize 
their diseases — the illness experience. Prior 
Abstract 
Dermatologic diseases have a similar influence on 
quality of life (QoL) and disability as other chronic 
medical conditions. Although QoL has been studied 
in relation to acne, eczema, and psoriasis, there is 
little information on how patients conceptualize their 
diseases — the illness experience. More information 
about illness perception (IP) and the impact of these 
perceptions on QoL, will help clinicians identify and 
address patients’ conceptions, with the potential to 
positively impact patients’ wellbeing. We sought to 
examine the effect of IP on QoL and make 
comparisons across acne, psoriasis, and eczema 
among a diverse population. A cross-sectional 
survey-based study was completed anonymously by 
patients presenting to an urban university hospital-
based dermatology clinic. In our final model, we 
showed that IP was independently associated with 
overall QoL. A secondary finding showed that overall 
QoL was significantly worse for nonwhite patients 
compared to white patients. Our results are based on 
patient survey data, without correlation with 
objective clinical information. Taken together, our 
data demonstrate a direct relationship between IP 
and QoL in three common dermatologic conditions 
in a clinic-based setting and suggest that this 
relationship may be influenced by group differences, 
such as race/ethnicity. 
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research has focused more on psychological 
sequelae of depression and anxiety [18] and 
personality traits [19]. More information about IPs in 
common dermatologic conditions and the impact of 
these perceptions on QoL, will help clinicians identify 
and address patients’ conceptions, with the 
potential to positively impact patients’ health and 
wellbeing. To explore this subject, a survey-based 
study of IP and QoL was undertaken in an ethnically-
diverse urban university hospital-based 
dermatology clinic. 
 
Methods 
Study Design 
The study was approved by the Institutional Review 
Board at Weill Cornell Medicine (WCM), and analyzed 
data from a cross-sectional survey of patients 
presenting to the WCM Dermatology outpatient 
clinic in New York, New York from March-April 2017. 
All patients presenting to the clinic on a given day 
were sequentially offered the survey as they 
checked-in for their appointment; approximately 
85% opted to participate. Patients with a self-
reported diagnosis of acne, psoriasis, or eczema were 
administered the survey prior to their visit with their 
physician, thus excluding patients that were given a 
new diagnosis on that day. Demographics (age, 
gender, race/ethnicity), dermatologic diagnosis, 
time since diagnosis, number of treatments utilized, 
illness severity, IP, and QoL were assessed. The 
primary objectives of this study were to analyze the 
effect of self-reported measures of IP on self-
reported QoL and compare IP and QoL across three 
common dermatologic diagnoses. 
Severity 
Patients reported illness severity on a scale of 1 (very 
mild) to 10 (severe). They reported time since 
diagnosis (in years) and total number of treatments 
utilized. 
Quality of Life 
Impact on QoL was measured using the 
Dermatologic Life Quality Index (DLQI), a 
questionnaire developed based on interviews of 
patients with various dermatologic conditions. 
Questionnaire design and validation is detailed by 
Finlay et al. [20]; its utilization has increased in the 
last decade as an outcome in dermatologic research 
[21]. Each of the 10 items consisted of a response 
from 0 (not relevant/not at all) to 3 (very much). An 
overall score (with a maximum of 30) and subscale 
scores can be calculated. These included symptoms 
and feelings, daily activities, leisure, work and school, 
personal relationships, and treatment. Both overall 
score and subscales were analyzed. Higher scores 
indicate worse overall QoL. 
Illness Perception 
Illness perception was measured using the Brief 
Illness Perception Questionnaire, a nine-item scale 
developed to assess the cognitive and emotional 
representation of illness. Questionnaire design and 
validation has been detailed by Broadbent et al. [2]. 
For this study, only the first eight multiple-choice 
items were included and the ninth item “Please list in 
rank-order the three most important factors that you 
believe caused your illness” was omitted. Each of the 
eight items consisted of a response from 0 to 10. An 
overall score was calculated (with a maximum score 
of 80), along with individual item scores for 
consequences, timeline, personal control, treatment 
control, identity, concern, coherence, and emotional 
response. Higher scores on individual items and 
overall score indicate a more threatening view of the 
illness; owing to this, three items were reverse coded. 
Race/Ethnicity 
Race/ethnicity was self-selected by each participant. 
Categories included “White, ” “Black or African 
American,” “Asian or Asian American,” “Hispanic or 
Latino,” and “Other.” For the purpose of statistical 
comparisons, patients were also grouped into two, 
identifying them as either “white” or “nonwhite” 
(including all other race/ethnicities). 
Statistical Analysis 
All statistical analysis was completed using IBM SPSS 
Statistics Version 24. Normality of the data was 
assessed by examining boxplots and using the 
Shapiro-Wilks test. Continuous variables with a 
normal distribution were analyzed using analysis of 
variance to compare between diagnosis groups. 
Variables that were non-normally distributed were 
compared using Kruskall-Wallis tests. Post-hoc 
analyses were made with Bonferroni adjustments.  
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Comparisons between racial/ethnic groups (white 
versus nonwhite) with normally distributed data 
were examined using Independent Sample t-test, 
whereas data not normally distributed were 
examined using the Mann-Whitney U test. Chi-
Square tests were used to examine differences in 
gender or race/ethnicity between diagnosis groups. 
Multivariable linear regression was used to examine 
the independent effects of predictor variables of 
interest on QoL. 
 
Results 
Population 
The study included 132 individuals: 61 patients with 
acne, 24 patients with psoriasis, and 47 patients with 
eczema (Table 1). The entire study cohort included 
45 males and 87 females with a mean age of 40 years 
(range, 16-88 years). 
Demographic characteristics 
One-way ANOVA demonstrated that there was no 
significant difference among the three diagnosis 
groups with respect to time since diagnosis, number 
of treatments, illness severity, or IP. Patients with 
acne were significantly younger than patients with 
eczema (mean difference=-14.4, P<0.001) and 
psoriasis (mean difference=-19.6, P<0.001). Chi-
Square tests demonstrated no significant difference 
in the distribution of males and females within each 
diagnosis group (Chi-square=5.45, P=0.065), but 
there was a significant difference within 
race/ethnicity based on diagnosis group (Chi-
square=15.05, P=0.020), with white patients 
representing the majority of patients with psoriasis 
(Table 1). 
Brief Illness Perception 
There was a significant difference for items of 
timeline [F(2, 127)=9.952, P<0.001) and 
understanding [F(2, 129)=4.235, P=0.017), but not for 
overall IP among diagnosis groups [F(2, 129)=0.434, 
P=0.649]. Post-hoc analysis showed that patients 
with acne believed, on average, that their illness 
would continue for a shorter duration than patients 
with psoriasis (mean difference=-2.507, P<0.001) and 
patients with eczema (mean difference=-1.898, 
P=0.002). Post-hoc analysis also showed that 
patients with acne demonstrated better illness 
understanding compared to those with psoriasis 
(mean difference=-1.711, P=0.014), (Table 2). 
Nonwhite patients demonstrated significantly worse 
overall IP compared to white patients (t(129)=-3.43, 
P<0.001). For individual items, nonwhite patients 
reported worse impact on their identity, more 
Table 1. Demographic and Study Variables in the 3 Diagnosis Groups. 
 
 Acne Psoriasis Eczema 
N 61 24 47 
Sex, N (%)    
     Male  17 (27.9) 13 (54.2) 15 (31.9) 
     Female  44 (72.1) 11 (45.8) 32 (68.1) 
Race, N (%)     
White  27 (44.3) 17 (70.8) 22 (47.8) 
Black or African American 17 (27.9) 1 (4.2) 5 (10.9) 
Hispanic or Latino 11 (18.0) 1 (4.2) 10 (21.3) 
Asian or Asian American 6 (9.8) 5 (20.8) 9 (19.6) 
Mean age, y (SD) 31.3 (11.2) 51.0 (18.2) 45.8 (18.1) 
Illness Duration, y 8.8 (9.2) 9.0 (11.1) 12.4 (14.3) 
Number of Treatments 4.3 (2.9) 2.9 (2.2) 4.1 (4.6) 
Mean DLQI (SD) 5.6 (5.3) 7.5 (6.1) 8.3 (5.8) 
Mean Illness Perception (SD) 43.1 (12.1) 45.7 (12.8) 44.1 (10.8) 
 
Patients who completed the entirety of the survey but did not meet one of the three diagnostic criteria were also excluded from the final analysis. 
A total of 5 patients who omitted more than one item in a given scale of either Illness Perception or Dermatologic Quality of Life were excluded 
from the sample analysis. Three patients omitted a single item in Illness Perception, and for these patients that item was treated as a score of “0.”
 
Volume 25 Number 5| May 2019| 
25(5): 3 
 
5 
- 4 - 
Dermatology Online Journal  ||  Original Article
concern, and more emotional impact compared to 
white patients; however, they reported greater 
coherence of their illness than white patients. Post-
hoc analysis showed differences between groups for 
overall IP is driven by Hispanic or Latino patients 
compared to white patients (mean difference=8.48, 
P=0.019). Hispanic or Latino patients scored 
significantly worse on illness consequences 
compared to white patients (mean difference=1.80, 
P=0.034). All nonwhite groups including Black or 
African American (mean difference=-2.55, P<0.001), 
Asian or Asian American (mean difference=-2.026, 
P=0.016), and Hispanic or Latino (mean difference=-
2.712, P<0.001) scored significantly worse on 
concern relative to white patients, but with no 
significant difference among nonwhite groups 
(Table 3). 
Dermatologic Life Quality Index 
Dermatologic Life Quality Index scores deviated 
from a normal distribution, so the Kruskall-Wallis H 
test was used to compare medians across diagnosis 
groups. There was a significantly different overall 
DLQI score between diagnosis groups, χ2 (2)=7.927, 
P=0.019. There were significant differences for 
subscales of Symptoms and Feelings (χ2 (2)=10.213, 
P=0.006) and Daily Activities (χ2 (2)=5.999, P=0.050), 
(Table 2). 
Mann-Whitney U test showed significant differences 
between white and nonwhite patients on overall 
DLQI (U=1251.5, P<0.001) as well as on subscales of 
Symptoms and Feelings (U=1414.0, P<0.001), Daily 
Activities (U=1319.0, P<0.001), Leisure (U=1324.0, 
P<0.001), Work and School (U=1758.5, P=0.014), and 
Personal Relationships (U=1713.0, P=0.014), with 
nonwhite patients scoring consistently worse on all 
measures (Table 3). 
Multivariable linear regression was utilized to 
examine cumulative effects of all variables of interest 
on DLQI. The final model included Dermatologic Life 
Quality Index as the dependent variable with fixed 
factors including gender, race/ethnicity, and 
diagnosis. Covariates included age, illness severity, 
and IP. We found significant main effects for 
race/ethnicity, diagnosis, and IP. For a diagnosis of 
acne compared to a diagnosis of eczema, DLQI was 
on average 3.26 points lower (B=-3.261, 95% CI=-
5.247- -1.274, P<0.001), indicating better DLQI in the 
former. White patients, compared to nonwhite 
patients, had an average DLQI 2.261 points lower (B=-
2.261, 95% CI=-4.058-0.464, P=0.014), indicating  
Table 2. Comparisons among patients with acne, psoriasis, eczema. 
 
 Acne Psoriasis Eczema Significance p 
Brief Illness Perception Mean Scores (S.D.) 
Consequences 5.4 (2.6) 5.0 (2.7) 4.8 (2.7) .514
Timeline* 5.7 (2.7) 8.2 (2.2) 7.6 (2.9) <.0001 
Personal Control 6.7 (2.4) 6.2 (2.5) 5.9 (2.3) .254 
Treatment Control 4.4 (2.3) 4.7 (2.7) 4.3 (2.3) .853
Identity 5.0 (2.5) 5.1 (2.1) 5.8 (2.2) .154
Concern 6.1 (2.8) 6.2 (2.9) 6.1 (2.8) .958 
Understanding* 3.7 (2.4) 5.4 (2.6) 4.0 (2.3) .017
Emotional Response 6.0 (2.8) 5.0 (2.9) 5.6 (3.1) .382
Illness Perception 43.1 (12.1) 45.7 (12.8) 44.1 (10.8) .649 
Dermatology Life Quality Index Median Score (Interquartile Range 25th-75th %) 
Symptoms and Feelings* 2.0 (1.0-4.0) 3.0 (1.2-4.0) 3.0 (2.0-4.0) .006
Daily activities* 0.0 (0.0-2.0) 0.5 (0.0-2.0) 2.0 (0.0-3.0) .050
Leisure 0.0 (0.0-2.0) 0.0 (0,0-1.0) 1.0 (0.0-2.0) .535
Work and School 0.0 (0.0-0.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) .156 
Personal Relationships 0.0 (0.0-1.0) 0.0 (0.0-2.0) 0.0 (0.0-2.0) .689
Treatment 0.0 (0.0-1.0) 1.0 (0.0-1.0) 0.0 (0.0-1.0) .057
DLQI* 4.0 (1.0-9.5) 4.0 (2.2-13.0) 7.0 (4.0-11.0) .019 
Volume 25 Number 5| May 2019| 
25(5): 3 
 
5 
- 5 - 
Dermatology Online Journal  ||  Original Article
higher DLQI. Finally, IP is significantly associated with 
DLQI, with a 0.192 point increase in DLQI for every one 
point increase in IP (B=0.192, 95% CI=0.101-0.282, 
P<0.001), indicating a direct relationship between a 
more threatening view of illness and worse DLQI 
(Table 4). 
 
Discussion 
Illness Perception and Quality of Life 
This study examined IP and its effect on QoL 
(measured by DLQI as a surrogate) among three 
dermatologic conditions, acne, psoriasis, and 
eczema, which were chosen owing to their relative 
prevalence in dermatologic practice. We found 
significant differences in IP and overall DLQI among 
patients with these three diagnoses. Although IP 
overall score was not significantly different among 
the three groups, acne patients had a more favorable 
view of their disease timeline and reported greater 
understanding of their condition. These findings are 
consistent with clinical practice, as most patients 
with acne have shorter, more predictable courses, 
whereas patients with psoriasis and eczema typically 
have more chronic and fluctuating courses. Acne 
patients may report greater understanding of their 
disease given its relative prevalence or its presence 
in the popular media and press [22]. Overall DLQI  
differed significantly among diagnosis groups, with 
acne patients demonstrating better DLQI, primarily 
related to less impairment in daily activities, and 
symptoms and feelings, compared to patients with 
psoriasis or eczema. These findings are supported by 
the literature, in which patients with eczema and 
psoriasis had similar levels of DLQI disturbances, 
which were worse than in patients with acne [23, 24]. 
In our final model, we showed that IP was 
independently associated with overall DLQI, even 
after controlling for other variables, a finding 
supported by the literature. For example, in 
individuals with atopic dermatitis, illness beliefs 
predicted symptoms of depression and upset [4]. In 
a study by Fortune et al., the majority of patients with 
psoriasis reported that their illness had major 
consequences on their lives and affected their self-
perception [5]. Scharloo et al. found that in patients 
with psoriasis, strong illness identity, passive coping, 
belief in a long illness duration, and belief in strong 
consequences were associated with worse measures 
of functioning [6]. Cognitive and emotional 
representations of illness are also associated with 
subjective health complaints in patients with 
psoriasis [25]. One proposed theory posits that a 
process of cognitive sensitization leads to objective 
changes in a patient’s experience of illness through 
cognitive bias (such as increased attention to, or  
Table 3. Comparisons between White patients versus Nonwhite patients. 
 
 White Nonwhite Significance p Mean Difference (S.E.) 
Brief Illness Perception Mean Scores (S.D.) 
Consequences* 4.2 (2.3) 5.9 (2.7) <0.001 -1.6 (0.45)
Timeline 6.8 (3.1) 6.8 (2.8) 0.979 -0.01 (0.51)
Personal Control 6.2 (2.3) 6.4 (2.6) 0.587 -0.23 (0.43) 
Treatment Control 4.2 (2.2) 4.6 (2.5) 0.393 -0.35 (0.41)
Identity* 4.6 (2.3) 5.9 (2.2) <0.001 -1.3 (0.41)
Concern* 4.9 (2.5) 7.3 (2.5) <0.001 -2.4 (0.45)
Coherence* 4.8 (2.5) 3.4 (2.3) 0.002 1.3 (0.42) 
Emotional Response* 4.5 (2.7) 6.8 (2.7) <0.001 -2.2 (0.48) 
Illness Perception* 40.5 (11.6) 47.4 (11.1) <0.001 -6.8 (1.9) 
Dermatology Life Quality Index Median Score (Interquartile Range 25th-75th %)
Symptoms and Feelings* 2.0 (1.0-3.2) 4.0 (2.0-4.0) <0.001 ------- 
Daily activities* 0.0 (0.0-1.0) 1.0 (0.0-3.5) <0.001 ------- 
Leisure* 0.0 (0.0-1.0) 2.0 (0.0-3.0) <0.001 ------- 
Work and School* 0.0 (0.0-0.0) 0.0 (0.0-1.0) 0.014 ------- 
Personal Relationships* 0.0 (0.0-0.0) 0.0 (0.0-2.0) 0.014 ------- 
Treatment 0.0 (0.0-1.0) 0.0 (0.0-1.0) 0.221 ------- 
DLQI* 3.0 (1.8-7.0) 8.0 (4.0-12.0 <0.001 ------- 
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worrying about, negative aspects of their health or 
condition), [25].  
Race/ethnicity and IP and QoL 
A secondary, but important finding in our study, was 
the differences in both IP and DLQI between white 
and nonwhite patients. Nonwhite patients had worse 
overall IP compared to white patients, with 
differences in IP subscales of identity, concern, 
coherence, and emotional response. Overall DLQI was 
also significantly worse for nonwhite patients, with 
additional differences in subscales of symptoms and 
feelings, daily activities, leisure, work and school, and 
personal relationships. Race/ethnicity remained a 
significant predictor of DLQI even after controlling for 
gender, diagnosis, age, severity, and IP. These findings 
are consistent with previous studies. For example, 
Callender et al. found that nonwhite women had 
more misconceptions about acne than white women 
[26]. Rendon et al. found that nonwhite patients 
expected more immediate improvement of their acne 
than did white patients [27]. Gorelick et al. studied 
acne-related QoL in females of different races and 
ethnicities and found that white patients experienced 
less negative impact on social functioning than non-
white patients [28]. Kerr et al. found that African 
American patients reported significantly worse 
psoriasis-related QoL compared to Caucasians and 
also reported greater psychological impact of their 
condition [29]. 
Differences among our white versus. nonwhite 
populations could be attributed to a number of 
factors, including healthcare disparities, clinical 
disease characteristics that vary by race/ethnicity, or 
physician-related factors, that together may influence 
health beliefs and QoL. Access to, and setting of, 
dermatologic care differ across racial/ethnic groups 
[34, 35]. Even after controlling for socioeconomic 
status, ethnic minorities experience inequality in 
insurance coverage, access, and quality of care [30]. In 
addition, they are more likely to receive treatment in 
emergency medical settings [36]. Clinical disease 
characteristics may vary among different racial/ethnic 
groups [31]. Disease patterns among skin of color put 
patients at risk for being diagnosed at later stages [32] 
and present unique complications such as post-
inflammatory hyperpigmentation [31] and scarring 
[33]. 
Comfort and attitudes among providers and patients 
may also influence experiences and outcomes. A US 
survey showed that 47% of dermatologists and 
dermatology residents reported that respondents felt 
that their medical training did not train them for 
diagnosing skin conditions in black patients. 
Nonwhite women with acne report that their 
race/ethnicity need more targeted therapies and 
prefer a healthcare professional with experience 
treating people of their race/ethnicity [26].  
Table 4. Multivariable Linear Regression Predicting Dermatologic Life Quality Index. 
 
Variable β Standard Error t Significance 95% CI (Lower) 95% CI (Upper)
Intercept 1.216 2.423 0.502 0.617 -3.581 6.014
Gender       
Male 0.425 0.929 0.458 0.648 -1.413 2.264
Female 0r -- -- -- -- --
Race/Ethnicity*       
White -2.261 0.907 -2.492 0.014 -4.058 -0.464
Nonwhite 0r -- -- -- -- --
Diagnosis*       
Acne -3.261 1.003 -3.250 0.001 -5.247 -1.274 
Psoriasis -0.420 1.240 -0.339 0.735 -2.874 2.035
Eczema 0 r -- -- -- -- --
Age -0.040 0.028 -1.447 0.150 -0.095 0.15 
Severity 0.301 0.226 1.328 0.187 -0.148 0.749
Illness Perception* 0.192 0.046 4.196 >0.0001 0.101 0.282
 
r Indicates that this group is the reference for the other comparison variable 
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Conclusion 
Limitations 
Our results are based on patient survey data, without 
correlation with objective clinical information, such 
as disease severity. These methods were chosen for 
the purpose of this initial project to maximize 
confidentiality and patient participation. Our study 
was not designed to examine racial and ethnic 
disparities; factors that could provide explanatory 
support for our findings, such as differences in the 
race/ethnicity of the providers, patient insurance 
status, and socioeconomic status, were not 
collected. We simplified analyses by grouping 
patients into racial/ethnic groups of white and 
nonwhite because this study was not powered to 
detect differences between individual racial/ethnic 
minorities. 
Implications and future directions 
Taken together, our data demonstrate a direct 
relationship between IP and QoL in three common 
dermatologic conditions in a clinic-based setting and 
suggest that this relationship may be influenced by 
group differences, such as race/ethnicity. To the best 
of our knowledge, our study is the first to assess this 
association in these specific conditions in a diverse 
clinical setting, while using these or similar 
structured measurement tools. Our results suggest 
that physicians should make an effort to understand 
their patients’ ideas and attitudes about their 
illnesses and their effect on quality of life. They also  
should be aware of how differences such as 
race/ethnicity may moderate IP and QoL. Future 
studies could include expanding the study to a larger 
geographically diverse population, with collection of 
additional data, including objective ratings of 
disease severity, socioeconomic factors, and 
clinician-related information (such as clinician 
race/ethnicity, and comfort level in assessing and 
addressing illness beliefs). Development of a tool for 
providers to easily and efficiently better identify 
inaccurate or distorted illness perceptions in the 
clinic setting could enhance patient-centered care, 
with potential impact on wellbeing and outcome. 
Efforts to increase education among dermatologists 
about the management of patients from different 
racial, ethnic, and socioeconomic background, with 
attention to how these factors influence illness 
perception and course of illness, may improve care 
and increase satisfaction amongst both patients and 
clinicians.  
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